Therapeutic plasma exchange in treatment of adrenoleukodystrophy

Therapeutic Apheresis

Volumn 4, Issue 5, 2000, Pages 338-341

  Bambauer, Rolf ^a,b   Schiel, Ralf ^a   Cordes, Heinz ^a   Latza, Reinhard ^a  

^a Institute for Blood Purification   (Germany)

^b NONE   (Germany)

Author keywords

Adrenoleukodystrophy; Paraparesis; Therapeutic plasma exchange; Very long chain fatty acids

Indexed keywords

ANTICOAGULANT AGENT; APOLIPOPROTEIN B; DEXTRAN SULFATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW MOLECULAR WEIGHT HEPARIN; VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; ADULT; ANTICOAGULATION; CASE REPORT; CONFERENCE PAPER; DEGENERATIVE DISEASE; HUMAN; IMMUNOADSORPTION; MALE; NEUROLOGIC DISEASE; PARAPLEGIA; PLASMAPHERESIS; PRIORITY JOURNAL; SPASTICITY; TREATMENT OUTCOME; X CHROMOSOME LINKED DISORDER;

ADRENOLEUKODYSTROPHY; DATA INTERPRETATION, STATISTICAL; DIETARY FATS; FATTY ACIDS; FOLLOW-UP STUDIES; HUMANS; IMMUNOSORBENT TECHNIQUES; MALE; MIDDLE AGED; PLASMA EXCHANGE; TIME FACTORS;

EID: 0033739252     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2000.004005338.x     Document Type: Conference Paper

References (24)

1. X-linked adrenoleukodystrophy: Genes, mutations, and phenotypes
2. Lorenzo's oil
3. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transports
4. Adrenoleukodystrophy: Impaired oxidation of long-chain fatty acids in cultured skin fibroblasts and adrenal cortex
5. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy
6. X-linked adrenoleukodystrophy: Identification of primary defect at the level of a deficient peroxisomal very long-chain fatty acyl-CoA synthetase using a newly developed method for the isolation of peroxisomes from skin fibroblasts
7. Adrenoleukodystrophy: Phenotypic variability and implications for therapy
8. Adrenoleukodystrophy: Effects of dietary restriction of very long-chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids
9. A new dietary therapy for adrenoleukodystrophy: Biochemical and preliminary clinical results in 36 patients
10. Adrenoleukodystrophy: Dietary oleic acid lowers hexacosanoate levels
11. Dietary erucic acid therapy for X-linked adrenoleukodystrophy
12. A 2 year trial of oleic acid and erucic acid ('Lorenzo's oil') as treatment for adrenoleukodystrophy
13. Visual evoked potentials in adrenoleukodystrophy: A trial with glycerol trioleate and Lorenzo's oil
14. Improvement of clinical and MRI findings in a boy with adrenoleukodystrophy by dietary erucic acid therapy
15. Experience on therapy of adrenoleukodystrophy
16. Glyceroltrioleate/glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: Effect on clinical, biochemical, and neurophysiological parameters
17. Neurophysiologic follow-up of long-term dietary treatment in adult-onset adrenoleukodystrophy
18. Plasma exchange in children using IBM 2997, a dual-stage blood cell separator
19. Peroxisomes and neurologic diseases
20. Plasmapheresis in treatment of adrenoleukodystrophy
21. Diagnose von peroxisomalen erkrankungen - Erfahrungen mit einer empfindlichen massenfragmentographischen bestimmung der sehr langkettigen fettsauren und der phytansaure im plasma
22. Adrenoleukodystrophy: Increased plasma content of saturated very long-chain fatty acids
23. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation
24. Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III